You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase I Clinical Trial Candidates

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (VC005 tablets, VC005 Tablets Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • VC005 tablets
  • VC005 Tablets Placebo
  • (no location specified)
May 24, 2023

Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Newport Beach, California
  • +2 more
Nov 10, 2023

GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)

Recruiting
  • GBM
  • Postoperative radiotherapy for SVZ
  • Nanjing, Jiangsu, China
    Lining Guo
Oct 14, 2023

Advanced Malignancies Trial in Guangzhou (BRY812 for injection)

Not yet recruiting
  • Advanced Malignancies
  • BRY812 for injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital，Sun Yat-sen University
Sep 7, 2023

Advanced Solid Tumors Trial in Jinan, Shanghai (PM1003 Injection)

Recruiting
  • Advanced Solid Tumors
  • PM1003 Injection
  • Jinan, Shandong, China
  • +1 more
May 8, 2023

Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

Not yet recruiting
  • Liver Cancer
  • Stereotactic Body Radiation Treatment
  • Kansas City, Kansas
    University of Kansas Medical Center
Feb 13, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine(Sf9 cell)
  • (no location specified)
Mar 10, 2023

Healthy Trial in Shanghai (SR750 tablet, Placebo)

Recruiting
  • Healthy
  • SR750 tablet
  • Placebo
  • Shanghai, China
    Shanghai Clinical Research Center Phase I Clinical Research Unit
Mar 1, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Herpes Zoster Trial (Recombinant Zoster Vaccine, Placebo, Zoster Vaccine Recombinant, Adjuvanted)

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine
  • +2 more
  • (no location specified)
Feb 6, 2023

Healthy Trial (SHR-2001, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 4, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

Not yet recruiting
  • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  • JS203 for Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 11, 2022

Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

Not yet recruiting
  • Human Papillomavirus Infection
  • Human papillomavirus (HPV) Vaccine
  • Placebo
  • Canberra, Australia
    Paratus Clinical Research Canberra
Jan 4, 2023

NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 10, 2023

Relapsed/Refractory Multiple Myeloma Trial in China (LBL-034 for Injection)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • LBL-034 for Injection
  • Wuhu, Anhui, China
  • +6 more
Sep 24, 2023

Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

Not yet recruiting
  • Advanced Malignancies
  • 1A46 Drug Substance
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 4, 2023

Advanced Hepatocellular Carcinoma Trial in Hangzhou (CT0180 Cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • CT0180 Cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Jan 27, 2023

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

Advanced Malignant Tumors Trial in China (LBL-033 for Injection)

Not yet recruiting
  • Advanced Malignant Tumors
  • LBL-033 for Injection
  • Fuzhou, Fujian, China
  • +5 more
Mar 19, 2023

Solid Tumors, Adult Trial in Xuzhou (TIL injection)

Recruiting
  • Solid Tumors, Adult
  • TIL injection
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital Of Xuzhou Medical University
Oct 12, 2023

Advanced Solid Tumors Trial in China (SPH4336 Tablets)

Active, not recruiting
  • Advanced Solid Tumors
  • SPH4336 Tablets
  • Jinan, Shandong, China
  • +3 more
Jun 6, 2023

Healthy Trial (CM326)

Not yet recruiting
  • Healthy
  • CM326
  • (no location specified)
Jan 27, 2023